Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Apparently you did not comprehend some of the information in my post
<<<<<<<<<<<<< No, sales have not been happening with this KT deal >>>>>>>>>>>>>>>
There are 720 hour KT Tape Recovery + Wave products in Boots stores in the UK and Ireland.
KT would have needed to have BIEL do a 720 hour production run of the Wave, with new packaging, and then purchase these devices from BIEL. These 720 hour Wave devices started showing up in Boots stores in Q4 2023.
This tells us that KT is still placing orders with BIEL, Sales Have Been Happening With This KT Deal .
KT lost its exclusive deal for the US because they did not meet US quotas but is still a BIEL Partner.
https://www.boots.com/kt-recovery-wave-electromagnetic-pain-relief-device-10323038
BIEL submitted a Q-submission to the FDA for the RecoveryRX XTRA on 9/26/2022
This submission would have given BIEL a good idea as to what the FDA would require to Clear a RecoveryRx modified for more power.
https://www.linkedin.com/posts/keith-nalepka-8a6a9a124_innovation-team-opportunity-activity-6980539688419786752-47y9/
Different take on KT
<<<<<<<<< SALES were better prior to the deal with KT >>>>>>>>>>>
Sales in 2015, 2016, and 2017 were the highest in BIEL's History due to ActiPatch being in thousands of Boots stores. While the Sales were high so were the 'Total General and Administrative' costs. This caused a large 'Loss from Operations' each year. In 2018 BIEL got the NHS Tariff approval and BIEL wound down the Boots operation as the costs of those sales exceeded their revenue.
2021 reflects the revenue from 2 of the 3 KT orders. 2021 was the closest BIEL has ever come to profitability, even though Sales were less than the Boots years and BIEL had a lower margin, because the OEM business significantly cut expenses, see statistics below. An increase in sales is great but the bottom line is your sales minus the costs of generating those sales.
2015 - Sales = $2.33 million, TGA = $3.12 million, Ops Loss = $1.7 million
2016 - Sales = $2.08 million, TGA = $2.65 million, Ops Loss = $1.4 million
2017 - Sales = $1.76 million, TGA = $2.35 million, Ops Loss = $1.36 million
2018 - Sales = $1.04 million, TGA = $2.39 million, Ops Loss = $2.03 million
2019 - Sales = $.941 million, TGA = $1.86 million, Ops Loss = $1.33 million
2020 - Sales = $.829 million, TGA = $1.55 million, Ops Loss = $1.04 million (Sales were at $307k at end of Q3, first KT order received in Q4, 18 pallets)
2021 - Sales = $1.6 million, TGA = $.949 million, Ops Loss = $ .154 million (two more KT orders in Q2, 20 pallets and 14 pallets)
As far as KT promoting the Wave, KT is an athlete/weekend warrior brand. KT promoted to this market which is smaller than markets like , Chronic Pain, Osteoarthritis, Back Pain, ect.. KT's pricing decisions, $35 for 250 hours, also did not sit well with former ActiPatch customers who were used to paying $30 for 720 hours of therapy.
KT now has a 720 hour Wave selling in Boots' UK and Ireland stores for 35 GBP or $44 USD. So, KT is still marketing the BIEL made 'Wave', whether they will bring this new 720 hour product to the US market remains to be seen. As I have mentioned before the Wave is KT's only FDA Cleared Medical Device. With out the Wave KT is no longer a company selling Medical Devices, just another 'Wellness Product' company that can make no claims to treating any medical conditions.
Probably looking at the previous distributor, Harmony Health, they started in 2016
New distributor is Swedish HealthCare.
"Fredrik Samuelsson, 7-time decathlon champion, is one of those who has experienced the benefits of Actipatch."
"Actipatch has proven to be a game changer for people suffering from rheumatism and other painful conditions. The product is both easy to use and portable, making it a perfect choice for people who want to continue living an active life without pain or limitations. Fredrik Samuelsson, a 7-time decathlon champion, is one of those who has experienced the benefits of this product."
"Fredrik has experienced how painful and difficult it can be to maintain an active lifestyle with rheumatism. However, thanks to Actipatch, he has been able to manage his pain in a better way and continue to compete at a high level."
Alice, 29, Trollhättan.
Due to scoliosis, I have been putting uneven strain and strain on my back for a long time, which has led to overload and inflammation. Actipatch has reduced the pain significantly and the inflammation has subsided, which has helped me with the training significantly!
Back pain causes a lot of problems that affect everyday life a lot, so it's super cool that Actipatch can make such a big difference!
Bo Wejfeldt, 59 from Ängelholm.
I've always been very active and done all kinds of training as often as I could, mostly swimming and cross-country skiing. In recent years, I have had problems with inflammation of the tendons in my shoulder joint. It's at its worst when I need to move my arms a lot, so it has affected me a lot when I've been training and I haven't been able to do it as much as I wanted.
I've tried all kinds of painkillers to relieve the pain but the Actipatch is actually the first thing that worked. Already after a few hours of use, I noticed that the pain was significantly milder and can now exercise actively without hindrance!
I don't need to use any other medication, I have the Actipatch on daily, except in the shower and pool of course.
Anna Hörnell, 47 years old, Frösön
Due to a riding accident, I have a vertebra that is pressed down and also a herniated disc on another vertebra. Because of the pain from the vertebrae, I have been taking painkillers daily for many years and also slept badly at night – I have only been able to lie on my left side. I've probably tried most things in pain relief but nothing that has helped me. I met Camilla who told me about ActiPatch and I thought "Why not?!"; So I tried one for back pain. To be honest, I didn't believe this contraption at all... Imagine my surprise when I already after an hour felt an improvement, coincidence I thought, it can't work. I went to bed and woke up on my stomach! I had slept all night! That's probably the biggest change, that I can sleep at night.
I've stopped taking painkillers daily, but I still need them sometimes. I can highly recommend trying ActiPatch – it has helped me a lot!
Janne Lindroth, 55 years old
My name is Janne and I'm 55 years old and very active, running, skiing, both downhill and crosswise, playing golf (hcp 6,8).
A year ago I got a lot of pain in my right shoulder and thought it would go away as usual. But no, it got worse and worse and finally I got my arm up max 90 degrees. Went to the doctor, found frozen shoulder, calcium shoulder, got medicine and was advised to take cortisone if it didn't help. The medicine didn't help and I didn't want to take a cortisone shot.
At that point, I heard about ActiPatch and of course I got curious and gave it a try.
Today, 4 weeks after I put the Actipatch on my shoulder, I can stretch out and up my arm as usual – unbelievable!!
Roland Björkman, PhD, Registered Nurse, B.A.
I am 65 years old and crashed my motorcycle on a patch of mud this summer. Then I got a right-sided shoulder injury that I initially ignored. Perceived the injury as a muscle and ligament strain/sprain that should heal after a few days/weeks. Unfortunately, the pain only got worse and I took a week's treatment with antiphlogistic (Voltaren). Then I got better and could sleep without having to turn over and "pile up" with extra pillows. But when I stopped the pill treatment, the problems that I tried to live with returned. The salvation came when I found out about the Actipatch at the Senior Fair and ordered a package. Within a few days I became pain-free, which was very surprising since I had had the problems for about 6 months. Since then I have been free of symptoms.
In the case of a later tennis arm (epicondylitis) with classic point-like pain over the muscle/tendon attachment of the elbow, I started treatment with AP. Even then, I was almost overnight free of the symptoms. Have not had any side effects/side effects of the treatment, which is outstanding with such an effective treatment. However, I have used "skin-friendly" adhesive to attach the AP instead of the enclosed patches that I found difficult to handle.
Yep bieliever, as of 3/31/2023 Dr Staelin had $2.19 million in loans to BIEL
<<<<<<<<<<<<< he has a lot at stake >>>>>>>>>>>>>>>
Since he rejoined the BOD in 2020 he has made 18 'interest only' loans to BIEL totaling over $830,000 .
He has probably made several hundred thousand dollars in new loans over the last 9 months.
What a Steamy Load of BS, what else should we expect from the creator of fraudulent Sales Track
<<<<<<<<<<<<<< long and strong letting 2's go now >>>>>>>>>>>>>>>>>
With a Total Volume of over 28 million shares a pitiful 1.7 million was sold at 2.
25 million shares purchased at 3 .
A second day of Total Domination by Longs.
Interesting that someone would choose a day with 18x more Buying than Selling to promote an opinion like "it seems we're hitting a new low", I guess one has to consider the source and their agenda.
Buys = 34.6 million shares @ 3
Sells = 1.9 million shares @ 2
Same answer as last time you asked this question
srinsocal = 14 years on this board and 6,200 posts
ddls = 15 years on this board and 27,000 posts
Who is spending too much time?
Never answered this question, "What kind of a person spends 15 years of their life, 27,000 posts, trying to destroy a penny stock?".
15 years of failing to destroy BIEL, quite a record
What kind of a person spends 15 years of their life, 27,000 posts, trying to destroy a penny stock?
If one examines the Time/Sales data it shows that the MMs were constantly refilling their bottomless bucket of phantom .0003 shares
This put them in the hole at the end of the day 29.5 million shares
Date .. Symbol .. Short vol ..Total vol
20231227 | BIEL | 29501726 || 39180965
Must be looking at the wrong stock
BIEL Closed at 3 .
Buys = 34.6 million shares
Sells = 1.9 million shares
Ya Gotta Look at Time/Sales to See the Full Picture
<<<<<<<<<< IT DON'T GO UP!!! IT ONLY GO DOWN!!! >>>>>>>>>>>>
19 Buys @ .0003 totaling 24.18 million shares
5 Sells @ .0002 totaling 210k shares
VWAP = .000298
Tuesday saw 24.6 million in Volume at the EOD
Today we have 24.2 million in Volume at 10:01 .
Nice Opening, Nicer Follow Up
At the Open 2 million share Buy.
9:53 - 10:01 22 million shares in Buys.
And then there is the NIH HEAL Initiative, specifically targeting Medical Devices
"More than 25 million Americans suffer from daily chronic pain, a highly debilitating medical condition that is complex and difficult to manage. In recent decades, there has been an overreliance on the prescription of opioids for chronic pain despite their poor ability to improve function and high addiction liability. This contributed to a significant and alarming epidemic of opioid overdose deaths and addictions. Innovative scientific solutions to develop alternative pain treatment options are thus critically needed."
"Through targeted research efforts, the NIH HEAL Initiative aims to support the development of safe and effective devices to treat pain with little or no addiction liability. This notice of funding opportunity (NOFO) is designed to support interdisciplinary research teams of multiple PDs/PIs to investigate the mechanisms of action of pain relief using FDA-approved or -cleared medical devices with the overall goal of optimizing therapeutic outcomes for these technologies. Program teams are expected to accomplish goals that require considerable synergy and collaborative interactions. Teams must leverage appropriate multi-disciplinary expertise to develop new principles and methods for experimentation, analysis, and interpretation. Project goals should not be achievable with a collection of individual efforts or projects. Teams are encouraged to consider objectives that will produce major advances in the understanding of pain relief by medical devices that are likely to improve strategies for pain management."
100 Percent False, 'No Pain Act' Passed Congress 12/23/2022, Takes effect in 2025
<<<<<<<<<<<<<<<< The no pain act is DEAD >>>>>>>>>>>>>>>>>
NOPAIN Act Basics
What is the NOPAIN Act?
The Non-Opioids Prevent Addiction in the Nation Act (“NOPAIN Act”) is a policy that will prevent opioid addiction before it starts by increasing the use of non-opioid pain management approaches in outpatient surgical settings.
What Will the NOPAIN Act Do?
The NOPAIN Act will increase the use of non-opioid pain management approaches by changing outdated federal reimbursement policies. The policy will:
Expand patient and provider access to FDA approved non-opioid pain management approaches in all outpatient surgical settings.
Require a report to Congress on limitations, gaps, barriers to access, or deficits in Medicare coverage or reimbursement for therapeutic services.
What is the Status of the NOPAIN Act?
The NOPAIN Act was passed in an end-of-year legislative package in the 117th Congress in 2022. As a result of the law, patients and providers will have expanded access to non-opioids starting in 2025.
Why Do We Need the NOPAIN Act?
This NOPAIN Act will ensure that safe, non-addictive therapies are widely available to the tens of millions of Americans who undergo an outpatient surgical procedure every year. Drug-related overdoses and deaths skyrocketed during the COVID-19 pandemic resulting in the highest rates ever recorded. This policy change aims to reduce unnecessary exposure to opioids and the likelihood of opioid abuse or addiction following an acute pain incident.
Thank you for the Update Dr. Staelin and for your continued financial support for BIEL
I am glad to see that BIEL published this update as a PR through Global Newswire so that those outside of the BIEL email list will see it.
(my comments in green)
End of Year Message From the Chairman of the Board of BioElectronics
FREDERICK, MD, Dec. 22, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioElectronics Corp. (OTC: BIEL) is pleased to provide this end of year message to investors, customers, suppliers and other partners. As described below, the last six months have produced mixed results.
Research Update
We have seen good progress on the research side. An investigator-sponsored study at University of California San Diego (UCSD) for phantom limb was completed this last fall and the paper is now under peer review for publication. All indications are that the results are very positive, but they are embargoed until they appear in press. The quality of life study for dogs diagnosed with osteoarthritis has been tentatively accepted and is now being prepared for final publication in Veterinary Medicine and Science. The results of this double-blind, placebo-controlled study show that the treated dogs showed significant improvement in functionality and mobility after 14 days of treatment above and beyond the current prescription medicines being taken. If this paper is published, we plan to start actively marketing our RecoveryRx line into the veterinary market.
( UCSD is one of the premier research universities in the US, people take notice when they publish a Study )
Two other clinical studies are now in the field. Stanford University is conducting a study on thumb arthritics and a second study at UCSD for post-surgical analgesia is expected to finish in June 2024.
( two heavy hitters in research, UCSD and Stanford, the Stanford Thumb Arthritis Study has a 2/28/2024 estimated completion date )
Finally, we completed a new design for our RecoveryRx product that is better suited for surgery incisions and is 50% more powerful than the current version. We have already manufactured a limited supply of these units and are planning to apply for an expedited 510(k) from the FDA in the near future.
( BIEL gave a teaser on this more powerful surgery incision RecoveryRx last year and now it is a reality with a confirmed power increase of 50% and a small production run with a 510k in the works, in today's 'Now' world having an ActiPatch/RecoveryRx with 50% more power is a major plus for customers )
Distribution Update
News on the sales front is more mixed. We brought in two new distributors for Bulgaria and the Netherlands and will relaunch in Australia in early 2024. However, talks with a major distributor in Asia and the CIS countries fell through after about six months of conversation. KT Tape had a change in management and decided not to actively market our medical device. As a result, we revoked its exclusive distributor contract and are now looking for a new distributor.
( CIS includes eastern European countries like Russia, Armenia, Belarus. Bulgaria has a 14 store chain handling ActiPatch, Pharmacy Remidum. KT lost their exclusive agreement in the US but they are still selling the Wave and are transitioning to a 720 hour Wave, the Boots chain in the UK and Ireland are now selling the 720 hour Wave. SAI, Surgery Appliance Industries, was not mentioned but they have renewed their Registration to sell their 10 'Powered By ActiPatch' products in the US for 2024, I am wondering what other info from the BIEL world was not in the Update )
Social Media Campaign
We launched a limited social media campaign to generate some sales and interest in our OTC product within the very lucrative US market. These direct to consumer (DTR) sales continue to result in strong consumer reviews. Aggregating the numerous product reviews (well over 1000) over the platforms selling our product shows that the vast majority (70% or more) of users give our product a 4 or 5 star rating. This figure is very similar to our published research findings that show about 66% of chronic pain sufferers find clinically significant relief within the first 7 days of use of our OTC product. Such findings have led to significant conversations with three major distributors who are in the pain space. However, to date, none of these conversations have resulted in a licensing or distribution agreement.
( direct to consumer sales cut out the distributor and retailer costs giving BIEL the full $35 of a US ActiPatch sale, "three major distributors in the pain space" sounds promising, keep knocking on those doors BIEL )
Need for Short-Term Financing
The lack of significant sales volume has severely limited the Company’s ability to actively market its product line. Most of the funding has come from inside investors (mainly myself). As has been the case for a number of years, the lack of positive cash flow has forced the Company to make many short-term decisions that have acted as a barrier for potential growth. It has also led to the Company looking for additional financing. The Company cannot provide assurances that it will be able to obtain the needed financing, on acceptable terms or otherwise. If the Company is unable to obtain short term financing, it is likely that the Company will need to explore strategic alternatives, including possible dissolution. In the event the Company does obtain financing, there can be no assurances the Company will be able to achieve any of the objectives or milestones described above.
( this is a standard 'Going Concern' or 'Safe Harbor' statement to warn prospective investors that the information presented may or may not happen, all of BIEL's Financial Statements carry a similar statement )
On a more positive note, BioElectronics would like to extend Season Greetings to all its customers and loyal shareholders. Here’s to everyone’s health and prosperity.
Richard Staelin
Chairman of the Board
This was a standard 'Safe Harbor' statement to reduce the risk of a lawsuit
Every BIEL Financial Statement and Press Release has something similar.
Yeah, Facts are inconvenient nuisances that get in the way of your "Bullshit Agenda" so better to ignore them.
Interesting that you feel the need to defend 'Mr. This is Fun' . Was it his astute analysis of the BIEL '30 Day Money Back Guarantee' that endeared him to you or are you just using him as a Tool for your "Bullshit Agenda"?
Market Makers will do whatever makes them the most money, period. Manipulating SP via Shorting is just one of their scams to create profits.
If you have looked at my posts on MM shorting you are aware that I have said this is Not 'Long Term Shorting'. Their Shorting could be Covered later that same day or up to 13 days later and it won't show up on the Bimonthly Short Report.
If you think that MMs are model citizens who entered the Market Making business to serve investors you don't follow the financial news:
New US SEC rules to shine a light on short selling
By Douglas Gillison and Chris Prentice, Reuters
October 13, 2023 1:12 PM PDT
"The U.S. Securities and Exchange Commission on Friday agreed to roll out new rules aimed at boosting transparency of short selling, the controversial practice of betting against stocks that drew new scrutiny amid the GameStop saga."
Data (D)Riven: SEC Sanctions Market Players for Trade Info Failures
by: Peter D. Hutcheon of Norris McLaughlin P.A. - Business Law Blog
Monday, November 6, 2023 National Law Review
'the SEC issued two enforcement Orders imposing sanctions on Goldman Sachs & Co. LLC (“Goldman Sachs,” a wholly owned subsidiary of The Goldman Sachs Group, Inc., characterized by the SEC as “a global financial services firm”) and on Citadel Securities LLC (“Citadel,” characterized by the SEC as “one of the largest broker-dealers in the U.S. equities market”). Each enforcement action imposed substantial civil penalties and other requirements because the respondent in each case failed to collect and report timely and accurate market information."
"The SEC imposed a series of financial sanctions on the “miscreants,” ranging from $2.5 million assessed on Scott Trade in 2014 for six years of inaccurate data; to $3.2 million assessed on Cantor, Fitzgerald & Co., which filed EBS’s containing 34,884,409 transactions with incomplete data; to $875,000 assessed on Morgan Stanley for 869 faulty EBS’s covering 156,678 options; to $7 million assessed on Citigroup in 2016 for inaccurate reports on 26,810 transactions."
Harvard Law School Forum, Posted by Haimavathi V. Marlier, Michael Birnbaum, and Nicole Serfoss, Morrison & Foerster LLP
Thursday, November 9, 2023
"SEC Charges Global Market Maker for False and Misleading Disclosures Regarding Efforts to Protect Customer Trading Data and Prevent Access to MNPI
On September 12, 2023, the SEC filed charges in the Southern District of New York against public company Virtu Financial Inc., one of the country’s largest electronic trading firms, and its broker-dealer subsidiary, Virtu Americas LLC (collectively, “Virtu”), for making allegedly false and misleading statements about how it safeguarded confidential customer trading data"
U.S. bankers urge SEC to probe short sales, reduce 'abusive' trading
By Andrea Shalal
May 4, 20237:11 PM PDT Reuters
"The American Bankers Association on Thursday urged federal regulators to investigate a spate of significant short sales of publicly traded banking equities that it said were "disconnected from the underlying financial realities." "We urge the SEC to consider all its existing tools and to take measures to reduce the avenues for abusive trading practices and restore investor confidence," the group said. "Short sellers raked in $378.9 million in paper profits on Thursday alone from betting against certain regional banks, according to analytics firm Ortex."
Citadel securities violations and fines
Investor Turf, Mar 13, 2023
US regulatory fines:
In 2007, Citadel Securities was fined $22,500 by FINRA for failing to properly report short interest positions.
In 2009, Citadel Securities was fined $3 million by the SEC for allegedly engaging in improper trading practices that artificially impacted the price of securities.
In 2014, the US Securities and Exchange Commission (SEC) fined Citadel Securities $800,000 for allegedly violating the market access rule, which requires firms to have adequate risk controls and supervisory procedures in place when providing direct market access to customers.
In 2015, Citadel Securities was fined $800,000 by the SEC for violating the Market Access Rule.
In 2015, Citadel Securities was fined $1.5 million by FINRA for violating various rules related to trading activities.
In 2016, Citadel Securities was fined $3.5 million by the SEC for violating the National Market System Plan governing the consolidated data feeds that disseminate stock prices and trades to the public.
In 2017, Citadel Securities was fined $22.6 million by the SEC for misleading customers about the quality of its pricing and execution.
In 2017, the US Financial Industry Regulatory Authority (FINRA) fined Citadel Securities $1.5 million for allegedly providing inaccurate information to customers and for failing to report trades to the appropriate regulatory entities.
In 2018, Citadel Securities was fined $3.5 million by the SEC for failing to provide customers with accurate trade data.
In 2019, Citadel Securities was fined $100,000 by the Commodities Futures Trading Commission (CFTC) for exceeding speculative position limits in wheat futures.
In 2020, Citadel Securities was fined $97,000 by FINRA for failing to properly report certain equity trades.
In 2020, the US Commodities Futures Trading Commission (CFTC) fined Citadel Securities $700,000 for allegedly violating swap data reporting requirements.
In 2021, Citadel Securities was fined $700,000 by FINRA for failing to report a significant number of trades to FINRA's Trade Reporting and Compliance Engine (TRACE).
Thanks for the meaningless statistics
<<<<<<<<<<<<< .0002 on the bid eight times today so far and printed two times. >>>>>>>>>>>>>>>
Two trades at 2 @ 9:30:00, totaling 143k shares or $28, on a day that saw over 9 million shares Traded, BFD !
Says the guy with over 27,000 posts
<<<<<<<<<<< Why do you even bother, spending so much time on this? >>>>>>>>>>>>>
In case you missed it, AW passed away several years ago. He is the one you hated not BIEL.
No, what's hysterical is that our MMs Shorted 51.6 million shares out of a 57.4 Total Volume
date...... Symbol .. Short Vol .. Total Vol
20231219 | BIEL | 51678374 || 57494707
Only 5.8 million shares, 10.1 percent, were Sold by someone who actually owned the shared they Sold.
Any stock in any Market can have their SP dropped with 89% Shorting.
19 Times at the Bid for .0002 and only 1 Trade for 50k shares, $10
<<<<<<<<<< 19 times .0002 appeared on the BID today >>>>>>>>>>>>
That is a bottom of the barrel batting average, nobody wants to Sell at 2 .
Meanwhile, 48 million Buys @ 3 , $14,000 .
Yep, actually 36 million in one bite, Buy Volume now up to 46 million.
Sorry for the confusion, I posted that Synergy/IMS info in March of 2023 but forgot that it had been obtained from a 2019 history found in the 'Wayback Machine'
Early this year Synergy became a part of the IMS Group which most likely caused their dormant website
https://imsgroup.com.np/venture/ims-group-synergy
https://imsgroup.com.np/venture-category/pharmaceutical-supplies
IMO, if one wanted to contact Synergy they would do it through IMS.
Ya gotta stay current on the latest news
<<<<<<<<<< Where is KT Tape's 720 hour version? >>>>>>>>>>>
The KT Wave 720 hour version has been available at Boots in the UK and Ireland for the last 3 weeks.
https://www.boots.com/kt-recovery-wave-electromagnetic-pain-relief-device-10323038
"Product details
The new KT Recovery+ Wave™ is a breakthrough in drug-free pain relief. We have taken clinically proven electromagnetic therapy from the clinician’s office and brought it to you as an easy to use and portable FDA cleared device. What was once an expensive, bulky clinical & sports therapy treatment is now lightweight, discreet, and wearable - to go wherever you go.
Produces sensation-free electromagnetic waves – modulating nerve activity to provide pain relief.
Reduces pain in tissue and joints associated with soreness, arthritis, and other musculoskeletal injuries.
Decreased pain improves sleep, physical activity, and quality of life.
First Time Use: Wear for a minimum of 12 hours per day for 2-3 consecutive days.
Use as needed. Recommended treatment duration (use time): Wear the device for a minimum of 12 hours per day, up to 24 hours daily.
720 hour model."
Thanks Hawk, Adcock Ingram expanding ActiPatch into another African country, Namibia, a neighbor to the northwest.
And you are the opposite, always negative, even if it requires making statements that you know are half truths or completely false
<<<<<<<<< You are constantly attempting to analyze some sort of positive >>>>>>>>>
Forgot to mention none of those trades were Sells
KW has $6+ Million Reasons to Make BIEL Successful
That is plenty of incentive to turn BIEL around.
Thanks toohot, we need strict contribution limits or our Congressional Reps will continue to vote in a manner that fills their campaign coffers rather than the best interest of their constituents.
One thing we can agree on, ENDV is a Scam
ENDV is currently trading at a sub penny SP and this is after a 1 for 1,000 RS in 12/2019. That is correct, if you had 1,000,000 shares before the Reverse Split you had 1,000 shares after the RS.
With ENDV's Market Cap currently hovering around $3 million they are trying to break off Sofpulse into a separate company and value it at $50 - 100 million.
The ENDV CEO and only BOD member has granted himself multiple 6 figure bonuses as the company shows yearly multi-million dollar losses.
This is what a Scam company looks like.
Meanwhile BIEL's CEO has foregone over $2 million in Loan Interest and has deferred her salary for several years.
BIEL's COB has loaned the company over a million dollars to keep BIEL in business.
Great post bielup, after reading it another product, using technology totally foreign to consumers, came to mind, Microwave Ovens
It took years to win over consumers to this new form of cooking but today it is hard to find a home without one.
I asked Chat GPT how microwave oven manufacturers won consumers over. The notes in red are my comments relating to BIEL.
The acceptance of microwave ovens by consumers was a gradual process that involved a combination of technological advancements, marketing efforts, and changing consumer lifestyles. Here are some key factors that contributed to the acceptance of microwave ovens:
Technological Advancements: The initial development of microwave ovens dates back to the 1940s, but it wasn't until the 1960s and 1970s that the technology became more refined and affordable for consumers. As the technology improved, microwave ovens became more reliable, efficient, and cost-effective.
(BIEL made the major break through in PEMF with the wearable ActiPatch, several upgrades have refined it over the past 20 years)
Convenience and Speed: Microwave ovens offered a revolutionary way to cook food quickly and conveniently. They drastically reduced cooking times compared to traditional methods, making them attractive to consumers who were increasingly looking for ways to save time in their busy lives.
(BIEL's 'convenience' is its wearable design, 'Speed' is still an issue that needs work in this 'want it now' society)
Educational Marketing: Manufacturers invested heavily in educating consumers about the benefits and uses of microwave ovens. Marketing campaigns emphasized the time-saving aspects, versatility, and energy efficiency of microwave cooking. Cooking demonstrations and promotional materials showcased the convenience and speed of preparing meals with microwaves.
(BIEL's 'Education', IMO, needs to focus on understanding how PEMF, something consumers can't see or feel, relieves pain, the zero side effects of ActiPatch, and the dangerous side effects of many pain relieving drugs, especially addictive Opioids)
Affordability: As production processes improved and competition increased, the cost of manufacturing microwave ovens decreased. This made them more accessible to a broader range of consumers, contributing to their acceptance.
(BIEL has the 'affordability' issue under control, however we did see the negative affect of high pricing with KT's Wave priced at $34.95 for 250 hours)
Changing Lifestyles: The 1970s and 1980s saw significant changes in family structures and lifestyles. More women entered the workforce, leading to busier schedules and a greater demand for quick and easy meal preparation. Microwave ovens aligned well with these changing dynamics, offering a solution to time constraints.
(The 'changing lifestyles' issue I see for BIEL is more consumers becoming concerned with drug use and actively seeking non-drug solutions to pain)
Product Innovation: Manufacturers continued to innovate and improve microwave oven designs, incorporating features such as different cooking modes, defrosting capabilities, and various sizes to meet the diverse needs of consumers.
(Last year BIEL stated that they had developed a rechargeable ActiPatch, another possibility is an ActiPatch with an adjustable frequency via smart phone, different frequencies for different indications, last year BIEL showed a surgical RecoveryRx with an antenna modified into a long rectangular shape to direct more energy to the surgical incision)
Regulatory Approval: As safety standards were established and met, consumers gained confidence in the safety of microwave ovens. This was crucial for overcoming initial skepticism about the potential health risks associated with microwave cooking.
(It took years but BIEL has the 'regulatory' issue well covered with 5 FDA indications, what is needed now is large clinical trials to satisfy the Health Insurance companies)
Word of Mouth and Positive Reviews: As more households adopted microwave ovens, positive word of mouth and reviews from satisfied users helped build trust in the product. Personal recommendations played a significant role in convincing others to try microwave cooking.
(As bielup pointed out, "4-5 star reviews from thousands of users means the product works!", but BIEL needs more to reach a 'Word of Mouth" critical mass)
In summary, the acceptance of microwave ovens by consumers was a result of a combination of technological progress, effective marketing strategies, changing societal trends, and the overall convenience that microwaves brought to the kitchen. Over time, microwave ovens became a staple in households around the world.
When a 'Tool' post knowingly false information I am going to correct the record, so sorry if this interferes with your propaganda campaign, you have dropped into the ddls tier of 'will do anything to destroy BIEL', why don't you start quoting Sales Track stats also.
art2426
Monday, November 27, 2023 4:19:36 PM
Post# 324388 of 324709
Is this true? .0002 on the bid all day today and it printed as a trade 6 times? (No this is not true and you were aware of that fact when you posted this BS)
.0002 was never "printed as a trade" on 11/27. Every time a Trade occurs at whatever price the Bid and Ask are updated in the Time/Sales data.
On 11/27 ihub had bad information that the Bid was .0002 . Fidelity, Schwab, Yahoo Finance, Investors Hub showed the correct .0003 Bid .
Fidelity Time/Sales data from 11/27:
Time & Sales
BIEL
11/27/2023
Hours: All
"Last Price","Last Size","Time",,,,"Exchange","Bid Price","Bid Size",,"Ask Price",,"Ask Size"
"0.0003",,,,,,,"75000","15:51:48 ET","OP",,,,,,,,"0.0003",,,"14743350",,"0.0004",,"83073090"
"0.0003",,,,,,,,,"8150","15:30:38 ET","OP",,,,,,,,"0.0003",,,,,"9301500",,"0.0004",,"83073090"
"0.0003",,,,,,,"70000","12:10:08 ET","OP",,,,,,,,"0.0003",,,,,"7747500",,"0.0004",,"81073090"
"0.0004",,,,,"999030","11:07:50 ET","OP",,,,,,,,,"0.0003",,,,"7747500",,"0.0004",,"82072120"
"0.0003",,,,,,,"15000","10:53:56 ET","OP",,,,,,,,,"0.0003",,"22362500",,"0.0004",,"78072120"
"0.0003",,,,,,,,,"4880","10:36:28 ET","OP",,,,,,,,,"0.0003",,"22362500",,"0.0004",,"77072120"
"0.0003",,,,,"100000","10:32:16 ET","OP",,,,,,,,,"0.0003",,"22362500",,"0.0004",,"77072120"
"0.0004",,,"1200000","09:32:59 ET","OP",,,,,,,,,"0.0003",,"21962500",,"0.0004",,"78272120"
"0.0003",,,,,"412500","09:31:53 ET","OP",,,,,,,,,"0.0003",,"22375000",,"0.0004",,"78272120"
"0.0003",,,,,,,"87500","09:31:27 ET","OP",,,,,,,,,"0.0003",,"22375000",,"0.0004",,"78272120"
"0.0003",,,,,"150000","09:30:02 ET","OP",,,,,,,,,"0.0003",..,"2335000",,"0.0004",,"31971606"
"0.0004",,,,,"100000","09:30:01 ET","OP",,,,,,,,,"0.0003",,,,"2335000",,"0.0004",,"31971606"
"0.0004",,,,,,,"20000","09:30:01 ET","OP",,,,,,,,,"0.0003",,,,"2335000",,"0.0004",,"31971606"
"0.0004",,,,,,,,,,,"120","09:30:00 ET","OP",,,,,,,,,"0.0003",,,,,,,,"20000",,"0.0004",,,,"4509900"
"0.0004",,,,,,,,,,,"120","09:30:00 ET","OP",,,,,,,,,"0.0003",,,,,,,,"20000",,"0.0004",,,,"4509900"
"0.0004",,,,,,,,,,,,,"25","09:30:00 ET","OP",,,,,,,,,"0.0003",,,,,,,,"20000",,"0.0004",,,,"4509
All of the information in my 11/27 post was correct. Fidelity, Schwab, Yahoo Finance all show a 'Low SP' of .0003 . If you have a problem with ddls and art misinformation being corrected with facts provide some 'Alternative Facts' and they will be shot down too.
ihub 'History' data from 11/27:
Date.......... Close .....Change..Change % . Open .... High ...... Low
Nov 27 2023 0.00035 -0.00005 -12.5% 0.0004 .... 0.0004 0.0003
https://ih.advfn.com/stock-market/USOTC/bioelectronics-pk-BIEL/historical
Fidelity Time/Sales data from 11/27:
Time & Sales
BIEL
11/27/2023
Hours: All
"Last Price","Last Size","Time",,,,"Exchange","Bid Price","Bid Size",,"Ask Price",,"Ask Size"
"0.0003",,,,,,,"75000","15:51:48 ET","OP",,,,,,,,"0.0003",,,"14743350",,"0.0004",,"83073090"
"0.0003",,,,,,,,,"8150","15:30:38 ET","OP",,,,,,,,"0.0003",,,,,"9301500",,"0.0004",,"83073090"
"0.0003",,,,,,,"70000","12:10:08 ET","OP",,,,,,,,"0.0003",,,,,"7747500",,"0.0004",,"81073090"
"0.0004",,,,,"999030","11:07:50 ET","OP",,,,,,,,,"0.0003",,,,"7747500",,"0.0004",,"82072120"
"0.0003",,,,,,,"15000","10:53:56 ET","OP",,,,,,,,,"0.0003",,"22362500",,"0.0004",,"78072120"
"0.0003",,,,,,,,,"4880","10:36:28 ET","OP",,,,,,,,,"0.0003",,"22362500",,"0.0004",,"77072120"
"0.0003",,,,,"100000","10:32:16 ET","OP",,,,,,,,,"0.0003",,"22362500",,"0.0004",,"77072120"
"0.0004",,,"1200000","09:32:59 ET","OP",,,,,,,,,"0.0003",,"21962500",,"0.0004",,"78272120"
"0.0003",,,,,"412500","09:31:53 ET","OP",,,,,,,,,"0.0003",,"22375000",,"0.0004",,"78272120"
"0.0003",,,,,,,"87500","09:31:27 ET","OP",,,,,,,,,"0.0003",,"22375000",,"0.0004",,"78272120"
"0.0003",,,,,"150000","09:30:02 ET","OP",,,,,,,,,"0.0003",..,"2335000",,"0.0004",,"31971606"
"0.0004",,,,,"100000","09:30:01 ET","OP",,,,,,,,,"0.0003",,,,"2335000",,"0.0004",,"31971606"
"0.0004",,,,,,,"20000","09:30:01 ET","OP",,,,,,,,,"0.0003",,,,"2335000",,"0.0004",,"31971606"
"0.0004",,,,,,,,,,,"120","09:30:00 ET","OP",,,,,,,,,"0.0003",,,,,,,,"20000",,"0.0004",,,,"4509900"
"0.0004",,,,,,,,,,,"120","09:30:00 ET","OP",,,,,,,,,"0.0003",,,,,,,,"20000",,"0.0004",,,,"4509900"
"0.0004",,,,,,,,,,,,,"25","09:30:00 ET","OP",,,,,,,,,"0.0003",,,,,,,,"20000",,"0.0004",,,,"4509900"
That was 2009 Arthur, 14 years ago
<<<<<< And how is not having enough money for such, not concerning to the stockholders? >>>>>>
So much for paying attention to details.
If one looks at the BIEL Financials history on the OTC Markets it shows that the last year BIEL was fully SEC reporting on a 10k form was 2009
BIEL explained the change at that time, it was too expensive for a small company to meet the SEC requirements, auditing, ect..
https://www.otcmarkets.com/stock/BIEL/disclosure